Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
General Neurology
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
e.g. reactive pleiocytosis, in light of publication from
Schimdauer et al in Eur J Neurol 2025 Apr
Related Questions
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
How do you approach the "wearing off" phenomenon for patients with multiple sclerosis on B-cell-depleting therapies?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
How would you manage a patient with LGI-1 encephalitis with faciobracial dystonic seizures who has not improved with 3 days of intravenous steroids?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?